Reduced efficacy of topical corticosteroid in preventing cytarabine-induced kerato-conjunctivitis in patients receiving high-dose cytarabine and total body irradiation for allogeneic hematopoietic stem cell transplantation

T. Mori, M. Watanabe, T. Kurotori-Sotome, C. Ito, K. Yamada, T. Yashima, N. Kobayashi, S. Kondo, Y. Aisa, J. Kato, Y. Ogawa, K. Tsubota, N. Shigematsu, A. Kubo, Y. Ikeda, S. Okamoto

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study aimed to retrospectively evaluate the incidence of kerato-conjunctivitis in patients receiving TBI followed by high-dose cytarabine, and to clarify how effectively topical corticosteroid eye drops prevent kerato-conjunctivitis in these patients. Fifty-three patients who received cytarabine at a dose of 3 g/m2 every 12h for 4 days after receiving TBI (12 Gy) as a conditioning for allogeneic hematopoietic stem cell transplantation (HSCT) were evaluated. For the prophylaxis of kerato-conjunctivitis, all patients received betamethasone sodium phosphate eye drops every 6h, starting 1 day before the first dose of cytarabine and continuing until 1 day after the last dose of cytarabine or the complete resolution of ocular symptoms. For grading of kerato-conjuncitivitis, the National Cancer Institute-Common Toxicity Criteria were used. Among the 53 patients, the grades of kerato-conjunctivitis were grade 0 in 13 patients, grade 1 in 6 patients (11.3%), grade 2 in 10 patients (18.9%) and grade 3 in 25 patients (47.2%). These results strongly suggest that topical corticosteroid eye drops could not effectively prevent the development of cytarabine-induced kerato-conjunctivitis in HSCT recipients who receive high-dose cytarabine following TBI. Further investigation into a more effective prophylaxis for cytarabine-induced kerato-conjunctivitis in this setting is required.

Original languageEnglish
Pages (from-to)197-199
Number of pages3
JournalBone Marrow Transplantation
Volume42
Issue number3
DOIs
Publication statusPublished - 2008 Jul 22

    Fingerprint

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this